First-in-Human Phase I Clinical Trial of Pharmacologic Ascorbate Combined with Radiation and Temozolomide for Newly Diagnosed Glioblastoma.

Authors

Bryan G Allen
Kellie L. Bodeker, George Washington University
Mark C Smith
Varun Monga
Sonia Sandhu
Raymond Hohl
Thomas Carlisle
Heather Brown
Nancy Hollenbeck
Sandy Vollstedt
Jeremy D Greenlee
Matthew A Howard
Kranti A Mapuskar
Steven N Seyedin
Joseph M Caster
Karra A Jones
Joseph J Cullen
Daniel Berg
Brett A Wagner
Garry R Buettner
Mindi J TenNapel
Brian J Smith
Douglas R Spitz
John M Buatti

Document Type

Journal Article

Publication Date

8-19-2019

Journal

Clinical cancer research : an official journal of the American Association for Cancer Research

DOI

10.1158/1078-0432.CCR-19-0594

Comments

E-pub ahead of print.

APA Citation

Allen, B., Bodeker, K. L., Smith, M., Monga, V., Sandhu, S., Hohl, R., Carlisle, T., Brown, H., Hollenbeck, N., Vollstedt, S., Greenlee, J., Howard, M., Mapuskar, K., Seyedin, S., Caster, J., Jones, K., Cullen, J., Berg, D., Wagner, B., Buettner, G., TenNapel, M., Smith, B., Spitz, D., & Buatti, J. (2019). First-in-Human Phase I Clinical Trial of Pharmacologic Ascorbate Combined with Radiation and Temozolomide for Newly Diagnosed Glioblastoma.. Clinical cancer research : an official journal of the American Association for Cancer Research, (). http://dx.doi.org/10.1158/1078-0432.CCR-19-0594

Peer Reviewed

1